Seminars in Hematology
Volume 41, Issue 2 , Pages 142-164, April 2004

Hereditary elliptocytosis: spectrin and protein 4.1R

  • Patrick G Gallagher

      Affiliations

    • Department of Pediatrics, Yale University School of Medicine, New Haven, CT, USA
    • Corresponding Author InformationAddress correspondence to Patrick G. Gallagher, MD, Department of Pediatrics, Yale University School of Medicine, 333 Cedar Street, PO Box 208064, New Haven, CT 06520-8064 USA

Abstract 

Hereditary elliptocytosis (HE) is a common disorder of erythrocyte shape, occurring especially in individuals of African and Mediterranean ancestry, presumably because elliptocytes confer some resistance to malaria. The principle lesion in HE is mechanical weakness or fragility of the erythrocyte membrane skeleton due to defects in α-spectrin, β-spectrin, or protein 4.1. Numerous mutations have been described in the genes encoding these proteins, including point mutations, gene deletions and insertions, and mRNA processing defects. Several mutations have been identified in a number of individuals on the same genetic background, suggesting a “founder effect.” The majority of HE patients are asymptomatic, but some may experience hemolytic anemia, splenomegaly, and intermittent jaundice.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Supported in part by grants from the National Institutes of Health and the March of Dimes Birth Defects Foundation.

PII: S0037-1963(04)00004-6

doi:10.1053/j.seminhematol.2004.01.003

Seminars in Hematology
Volume 41, Issue 2 , Pages 142-164, April 2004